-+ 0.00%
-+ 0.00%
-+ 0.00%

OSR Health CEO says two subsidiaries draw out-licensing interest as Nasdaq bid deadline nears

PUBT·08/11/2026 12:52:56
Listen to the news
OSR Health CEO says two subsidiaries draw out-licensing interest as Nasdaq bid deadline nears
  • OSR Holdings’ CEO said Nasdaq is expected to decide on continued listing by Aug. 18 if shares fail to close at $1.
  • Two subsidiaries received inbound out-licensing inquiries; one reached preliminary term-sheet talks, the other remains early-stage.
  • CEO said he has not bought more shares because he is already the largest investor and has funded multiple rounds to support R&D.
  • Management said it is working to preserve the Nasdaq listing organically while subsidiary business development accelerates.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OSR Holdings Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608110852ACCESSWRNAPR_____1206049) on August 11, 2026, and is solely responsible for the information contained therein.